Green Tea and Aging: What the Research Really Says

Green tea has long been considered a healthy beverage, and is sometimes attributed with properties of slowing down aging processes. It is important to distinguish between what research actually shows and marketing promises. The good news: green tea is a low-calorie beverage rich in polyphenols, and moderate consumption is considered safe and fits well into a healthy lifestyle. However, most claims about "rejuvenation" are based on experiments in cells and animals, not on direct proof in humans.

What is in green tea?

Green tea is produced from the leaves of the Camellia sinensis plant and contains active components, primarily catechins, led by EGCG (epigallocatechin gallate), which are polyphenols with antioxidant activity. These components are widely studied, but it is important to remember that antioxidant activity in a test tube does not automatically translate to a clinical benefit in humans.

• Antioxidants: The catechins in green tea help neutralize free radicals in laboratory models. The connection between oxidative damage and aging is complex, and not every dietary antioxidant extends lifespan.
• Anti-inflammatory activity: Chronic inflammation is linked to many age-related diseases. Green tea has shown anti-inflammatory effects mainly in laboratory and animal models. The effect in humans is being examined but is not established as a treatment.
• Brain health: Observational studies link green tea consumption to better cognitive function in older age. However, this is only an observational correlation, and there is no proof that green tea prevents neurodegenerative diseases like Alzheimer's or dementia. Causality has not been proven.
• Cancer: Evidence in humans is inconsistent. A 2020 Cochrane review (142 studies, over one million participants) found that the link between green tea and reduced cancer risk is inconsistent, and some studies even indicated a slight increase in risk for certain cancer types. Inhibition of cancer cell growth has been observed in vitro, but has not been proven as a preventive benefit in humans. A protective effect against cancer is not established.
• Heart health: Green tea may have a moderate effect on cardiovascular risk factors. Modest reductions in blood pressure and cholesterol have been observed in some studies, but this is a moderate effect and not a substitute for medication or lifestyle changes.
• Cellular mechanisms of aging: Researchers are examining whether green tea affects cellular processes related to aging, such as telomere length and mitochondrial function. It is important to emphasize: most evidence for this comes from cell and animal models (including mouse studies), not from direct proof in humans.

What does human research actually show?

The strongest human evidence is observational (linking habits to health outcomes, but not proving cause and effect). The large Ohsaki cohort study from Japan (Kuriyama et al., published in the journal JAMA in 2006, approximately 40,500 participants) found that green tea consumption was associated with lower all-cause mortality, and especially lower cardiovascular mortality. This is an observational correlation: green tea drinkers tend to have a healthier lifestyle overall, so the result cannot be attributed to tea alone. This study did not find a significant association with cancer mortality.

In short: green tea is consistently described as a healthy beverage in population studies, but claims about "rejuvenating the body" or "slowing the biological clock" rely mainly on laboratory and animal studies, and have not been directly proven in humans.

Safety: Tea vs. Concentrated Supplement (Important)

There is a fundamental difference between drinking regular green tea and taking a high-dose green tea extract / EGCG supplement:

• Regular brewed tea: Generally considered safe in reasonable amounts. It may cause mild gastrointestinal side effects and contains caffeine.
• Concentrated extract supplement: High-dose green tea extracts and EGCG supplements have been linked to an increased risk of liver damage. The European Food Safety Authority (EFSA) determined in 2018 that consuming EGCG at a dose of 800 mg per day or more from supplements may increase the risk of liver injury (elevated liver enzymes). There is no need for a concentrated supplement to enjoy tea as a beverage.

How to drink (not medical advice):

• Amount: In population studies, benefits were often observed in the range of about 3 to 5 cups per day. This is a range linked to benefits in observational studies, not a formal recommendation.
• Time of consumption: It is advisable to avoid green tea before bedtime due to the caffeine.
• Preparation method: Use hot water (not boiling) and steep for 2 to 3 minutes.
• Caution: Pregnant or breastfeeding women, people with liver disease or chronic illness, and those taking medications should consult a doctor, and especially avoid concentrated extract supplements without advice.

Background facts about green tea:

• Green tea is one of the most popular beverages in the world, originating in China where it has been consumed for thousands of years.
• It is made from the leaves of the Camellia sinensis plant and contains catechins, EGCG, and polyphenols.
• It has been extensively studied in the context of antioxidants and anti-inflammatory activity, but as mentioned, the evidence in humans regarding disease prevention is not conclusive.

Bottom line

Green tea is a healthy and tasty beverage that fits well into a healthy lifestyle, and population studies link it to better health. However, it is not a "fountain of youth": claims about slowing aging are based mainly on laboratory and animal models, and have not been directly proven in humans. Enjoy it as part of a balanced diet, but do not rely on it (and especially not on concentrated extract supplements) as a substitute for medical treatment. The information in this article is general and does not constitute medical advice.

References:

Kuriyama S, et al. Green Tea Consumption and Mortality Due to Cardiovascular Disease, Cancer, and All Causes in Japan: The Ohsaki Study. JAMA. 2006. https://pubmed.ncbi.nlm.nih.gov/16968850/

Filippini T, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database of Systematic Reviews. 2020. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005004.pub3/full

EFSA. Scientific opinion on the safety of green tea catechins. EFSA Journal. 2018. https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2018.5239